During the past decade, Virginia Center for Reproductive Medicine conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Virginia Center for Reproductive Medicine" are "Infertility" (3 trials), "Ovarian Hyperstimulation Syndrome" (1 trials), "Pregnancy" (1 trials) and "Premature Ovarian Failure" (1 trials). Many other conditions were trialed in "Virginia Center for Reproductive Medicine" in a lesser frequency.

Most popular intervention types in "Virginia Center for Reproductive Medicine" are "Drug" (3 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cetrotide acetate" (1 trials), "DHEA" (1 trials), "dehydroepiandrosterone" (1 trials), "menotropin" (1 trials) and "recombinant FSH" (1 trials). Other intervention names were less common.

The vast majority of trials in "Virginia Center for Reproductive Medicine" are 6 trials for "Female" genders.

Currently, there are NaN active trials in "Virginia Center for Reproductive Medicine". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Virginia Center for Reproductive Medicine, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Virginia Center for Reproductive Medicine, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".